Stephen Embury is a Hematology physician affiliated with Vanguard University. OpenAlex indexes 76 publications with 6,108 citations (h-index 30); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
108 Eagle Trace Dr
Half Moon Bay, CA 940192286
Telephone
415-203-0436Registry record last updated 14 Jun 2013.
Clinical trials
- TRF-1101 Assessment in Sickle Cell Disease
Sponsor: TRF Pharma, Inc
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Emmaus Medical, Inc.Program year20241 payment
- Emmaus Medical, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
6 NIH research awards on record, funded 1985–2017 per NIH RePORTER. The latest:
- Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy
Vanguard Therapeutics, Inc.
FY2017$324,169R44HL123059 - Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy
Vanguard Therapeutics, Inc.
FY2016$1,668,155R44HL123059
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sickle cell vaso-occlusion: The dialectic between red cells and white cells
Experimental Biology and Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Tait Shanafelt, MD
Palo Alto University
Robert Bast, MD
The University of Texas MD Anderson Cancer Center
Thomas Witzig, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”